New registry tracks fabry drug safety in pregnant women
NCT ID NCT06941025
First seen Apr 05, 2026 · Last updated May 29, 2026 · Updated 8 times
Summary
This study collects information from women with Fabry disease who took the medicine pegunigalsidase alfa around the time of pregnancy or while breastfeeding. Researchers will track pregnancy outcomes and baby health for up to a year after birth. The goal is to better understand the medicine's safety in these situations. About 10 women and their infants will take part over 10 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
No physical study sites - Decentralized, web-based registry
RECRUITINGWashington D.C., District of Columbia, 20001, United States
-
No physical study sites - Decentralized, web-based registry
RECRUITINGBerlin, Germany
-
No physical study sites - Decentralized, web-based registry
RECRUITINGRome, Italy
-
No physical study sites - Decentralized, web-based registry
RECRUITINGMadrid, Spain
-
No physical study sites - Decentralized, web-based registry
NOT_YET_RECRUITINGLondon, United Kingdom
Conditions
Explore the condition pages connected to this study.